Natural killer cells (NK) are the innate counterpart to CD8 T cells, endowed with the ability to rapidly kill virus-infected cells and cancer cells and produce proinflammatory cytokines (IFN?, TNF). These functional attributes make NK cells an attractive target for immunotherapy against multiple types of cancer, and they have been proven useful in graft versus leukemia. However, appropriate regulation of NK cell function is needed to avoid autoimmunity, immune deficiency, and NK cell transformation. Therefore, understanding how NK cell number and function are regulated is essential for the effective use of NK cells as therapeutic agents for eradication of disease. The mature NK cell population is composed of multiple phenotypically distinct subsets that have unique functional abilities. A subset of mature NK cells (mNK1), with a CD27+CD11b- phenotype, maintains the cytotoxic effector pool (CD27-CD11b+) as well as generating ?memory? NK cells. Our work seeks to understand the transcriptional basis for maintenance of the mNK1 population and the mechanisms controlling their differentiation and cytokine responsiveness. In this grant we will test the hypothesis that E protein transcription factors induce a transcriptional program that maintains the CD27+CD11b- precursor population and that this program is ID2 during effector maturation. We will also test the hypothesis that the transcription factor ETS1 collaborates with E proteins and E protein targets to control mNK1 differentiation and cytokine induced activation. This work will provide a foundation for understanding the mechanisms that control NK cell number and function and provide insight into the transcriptional network that can be manipulated to control the function of these cells in normal and diseased states.

Public Health Relevance

Natural killer cells are endowed with the ability to rapidly detect and kill virus-infected cells and cancer cells and play an important role in graft versus leukemia but can undergo leukemic transformation or contribute to autoimmunity when dysregulated. Work in this grant will determine the basic transcriptional networks that control the survival, expansion and differentiation of NK cells and will provide a foundation for controlling NK cells for therapeutic purposes.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Research Project (R01)
Project #
Application #
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Lapham, Cheryl K
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Chicago
Schools of Medicine
United States
Zip Code
Zook, Erin C; Li, Zhong-Yin; Xu, Yiying et al. (2018) Transcription factor ID2 prevents E proteins from enforcing a naïve T lymphocyte gene program during NK cell development. Sci Immunol 3:
Gabrielli, Sara; Sun, Mengxi; Bell, April et al. (2017) Murine thymic NK cells are distinct from ILC1s and have unique transcription factor requirements. Eur J Immunol 47:800-805
Verykokakis, Mihalis; Kee, Barbara L (2017) Applying the TOR(C)QUE in iNKT cells: A new twist in an old tale. Eur J Immunol 47:454-457
Jacobsen, Jennifer A; Woodard, Jennifer; Mandal, Malay et al. (2017) EZH2 Regulates the Developmental Timing of Effectors of the Pre-Antigen Receptor Checkpoints. J Immunol 198:4682-4691
Zook, Erin C; Ramirez, Kevin; Guo, Xiaohuan et al. (2016) The ETS1 transcription factor is required for the development and cytokine-induced expansion of ILC2. J Exp Med 213:687-96
Xu, Yiying; Evaristo, Cesar; Alegre, Maria-Luisa et al. (2015) Analysis of GzmbCre as a Model System for Gene Deletion in the Natural Killer Cell Lineage. PLoS One 10:e0125211
Guo, Xiaohuan; Liang, Yong; Zhang, Yuan et al. (2015) Innate Lymphoid Cells Control Early Colonization Resistance against Intestinal Pathogens through ID2-Dependent Regulation of the Microbiota. Immunity 42:731-43
Carr, Tiffany; Krishnamoorthy, Veena; Yu, Shuyang et al. (2015) The transcription factor lymphoid enhancer factor 1 controls invariant natural killer T cell expansion and Th2-type effector differentiation. J Exp Med 212:793-807
Krishnamoorthy, Veena; Carr, Tiffany; de Pooter, Renee F et al. (2015) Repression of Ccr9 transcription in mouse T lymphocyte progenitors by the Notch signaling pathway. J Immunol 194:3191-200
Verykokakis, Mihalis; Zook, Erin C; Kee, Barbara L (2014) ID'ing innate and innate-like lymphoid cells. Immunol Rev 261:177-97